# LGMD R1 Natural History Study

> **NCT05618080** · — · RECRUITING · sponsor: **Virginia Commonwealth University** · enrollment: 100 (estimated)

## Conditions studied

- Calpain-3 Deficiency Limb Girdle Muscular Dystrophy Type 2A
- Limb Girdle Muscular Dystrophy
- Limb Girdle Muscular Dystrophy Type R1
- LGMD2A

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05618080
- **Lead sponsor:** Virginia Commonwealth University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-31
- **Primary completion:** 2028-05
- **Final completion:** 2028-08
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-06-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05618080

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05618080, "LGMD R1 Natural History Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05618080. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*